Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
The immunostimulatory properties of TLR7/8 agonists, such as resiquimod, have been exploited for cancer immunotherapy. Here, the authors design platelet membrane-cloaked nanoparticles for selective intratumoral delivery of resiquimod, resulting in potent anti-tumor immune response in a range of prec...
Guardado en:
Autores principales: | Baharak Bahmani, Hua Gong, Brian T. Luk, Kristofer J. Haushalter, Ethel DeTeresa, Mark Previti, Jiarong Zhou, Weiwei Gao, Jack D. Bui, Liangfang Zhang, Ronnie H. Fang, Jie Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70f51776b4444f01b293b1d2b1518bff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Artificially cloaked viral nanovaccine for cancer immunotherapy
por: Manlio Fusciello, et al.
Publicado: (2019) -
Trial watch: intratumoral immunotherapy
por: Juliette Humeau, et al.
Publicado: (2021) -
Simple and effective bacterial-based intratumoral cancer immunotherapy
por: Teresa Neeman, et al.
Publicado: (2021) -
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice
por: Lei Lei, et al.
Publicado: (2021) -
Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis
por: Qiangzhe Zhang, et al.
Publicado: (2021)